ClariVest Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-192,398
| Closed | -$210K | – | 926 |
|
|
2023
Q3 | $210K | Sell |
192,398
-318,976
| -62% | -$348K | 0.01% | 370 |
|
|
2023
Q2 | $1.17M | Buy |
511,374
+121,213
| +31% | +$278K | 0.06% | 214 |
|
|
2023
Q1 | $949K | Buy |
390,161
+401
| +0.1% | +$975 | 0.04% | 289 |
|
|
2022
Q4 | $744K | Sell |
389,760
-3,031
| -0.8% | -$5.79K | 0.04% | 323 |
|
|
2022
Q3 | $943K | Buy |
+392,791
| New | +$943K | 0.05% | 265 |
|